Papers

1

Total Citations

26

H-Index

1

About

Dr. Jiangdong Qiu is a leading figure in pancreatic surgery, whose research has fundamentally advanced the field of minimally invasive pancreaticoduodenectomy. His work centers on comparing surgical outcomes for pancreatic cancer, with a particular focus on the safety and efficacy of robotic-assisted procedures versus traditional open surgery. Dr. Qiu’s landmark 2022 meta-analysis, which has garnered 26 citations, systematically evaluated perioperative outcomes between robotic and open pancreaticoduodenectomy, providing critical evidence on operative time, blood loss, and complication rates. This influential study has helped guide clinical decision-making for surgeons worldwide, demonstrating that while robotic approaches may offer certain advantages, careful patient selection remains paramount. Beyond this meta-analysis, Dr. Qiu’s broader contributions include advancing the understanding of lymph node harvest and R0 resection rates in pancreatic cancer surgery. His rigorous, evidence-based approach has established him as a key authority in surgical oncology, shaping best practices for one of the most challenging procedures in abdominal surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Meta-analysis of robotic versus open pancreaticoduodenectomy in all patients and pancreatic cancer patients
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago